查看购物车
  • Traditional Chinese
  • English
2021-2031年连续血糖监测设备市场规模及预测、全球及区域份额、趋势及成长机会分析报告涵盖：产品、应用、检测地点、最终用户及地理
市场调查报告书
商品编码
1858580

2021-2031年连续血糖监测设备市场规模及预测、全球及区域份额、趋势及成长机会分析报告涵盖：产品、应用、检测地点、最终用户及地理

Continuous Glucose Monitoring Device Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product, Application, Testing Sites, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 275 Pages | 订单完成后即时交付

价格

预计到2031年，持续血糖监测设备（CGMD）市场规模将从2024年的127.1亿美元成长至332.1亿美元。该市场在2025年至2031年期间的复合年增长率（CAGR）预计为14.9%。推动市场成长的主要因素包括全球糖尿病盛行率的上升、CGM设备的技术进步以及其优于传统血糖监测的优势，这些因素正在促进持续血糖监测设备（CGMD）的普及。此外，与胰岛素输注系统的整合以及人工智慧驱动的决策支援功能有望在预测期内进一步推动市场成长。然而，高昂的成本、有限的报销以及用户舒适度和佩戴体验方面的挑战是限制市场发展的因素。

与传统的血糖监测方法相比，持续血糖监测 (CGM) 设备具有显着且具有临床意义的优势，从根本上改变了全球数百万名糖尿病患者的管理方式。与依赖定期指尖采血的传统方法不同，CGM 透过微创感测器提供即时、连续的血糖值测量，使用户和临床医生能够评估血糖波动和趋势，而不是仅仅依赖单一资料点。近期临床研究表明，CGM 的使用可使糖化血红蛋白 (HbA1c) 水平降低 0.25% 至 3.0%，并将「目标范围内时间」（血糖水平在目标范围内的时间百分比）提高 15% 至 34%，这两项指标的提高均与降低糖尿病併发症风险和改善长期预后相关。

持续血糖监测 (CGM) 技术最具影响力的进展之一是其能够即时发出低血糖和高血糖警报。这些警报能够促使医护人员立即采取干预措施，例如及时补充碳水化合物或调整胰岛素剂量，从而显着降低危险事件的发生频率和严重程度。研究表明，新型 CGM 中整合的低血糖预测演算法可以将血糖低于目标范围的时间减少高达 92%（与无警报相比）和 47%（与标准警报相比），从而显着提高安全性，尤其是在睡眠期间或对于低血糖高风险患者而言。此外，夜间低血糖预测技术已证实可将夜间血糖低于安全阈值的时间减少 37%，从而在血糖脆弱时段提供有效保护。

持续血糖监测（CGM）是一种变革性的教育工具，它透过将饮食摄取、身体活动、药物反应和压力因素与相应的血糖波动关联起来，从而激励患者进行个人化的生活方式改变。这种持续的视觉回馈能够增强患者的自我管理能力和参与度，提供的洞察远胜于缺乏即时和个人化生理资料的传统教育方法。这种持续的资料流能够实现动态的糖尿病管理，使患者和医护人员能够做出积极主动、基于循证医学的决策，在两次就诊之间调整治疗方案，并识别出以前未被注意到的模式，例如餐后血糖峰值或夜间高血糖。

持续血糖监测（CGM）也能为医疗服务提供者提供详细且全面的血糖谱，包括目标范围内时间、低血糖/高血糖发生频率和血糖波动等指标。这有助于更精准地强化治疗、进行风险分层和製定预防策略，从而降低住院率并避免严重併发症。透过整合无线资料传输和云端存储，可以远端监测患者资料，从而简化医疗服务流程并提高患者依从性。这对于儿童、老年人、孕妇和低血糖感知障碍患者等弱势群体尤其重要。

持续血糖监测（CGM）消除了频繁指尖采血带来的实际和心理负担，而指尖采血正是早期血糖监测方法的一个局限性，影响了患者的依从性和生活品质。儿童尤其重视这种「无需指尖采血」的方法，接受强化治疗的患者儘管面临成本和设备复杂性方面的挑战，但仍报告了更高的治疗满意度和长期设备留存率。

持续血糖监测（CGM）显着改善了血糖控制指标，有效预防了低血糖，透过即时资料增强了患者的自主性，为医疗团队提供了可操作的指标支持，并提高了患者的整体生活品质。鑑于这些经临床验证的益处，国际糖尿病照护标准强烈建议将CGM用于第1型糖尿病，并不断扩大其在第2型糖尿病中的应用范围。这进一步巩固了CGM作为现代糖尿病照护基石的地位。

本报告透过比较分析，基于产品组合（产品满意度、产品特性和可用性）、近期市场发展（併购、新产品发布与改进、投资与融资、奖项、协议、合作与伙伴关係、认可和扩张）以及地域分布，对持续血糖监测设备 (CGMD) 市场进行评估和分类，从而帮助企业更好地进行决策併了解竞争格局。报告深入探讨了全球持续血糖监测设备 (CGMD) 市场领先供应商近期取得的重大进展和创新。主要市场参与者包括：雅培实验室 (Abbott Laboratories)、德康医疗 (Dexcom Inc.)、Ypsomed Holding AG、美敦力 (Medtronic)、罗氏 (F. Hoffmann-La Roche Ltd)、Senseonics Holdings Inc、i-SENS Inc.、A. Menarini Diagnostics srl、Tandem​​i 和 Diagnostics Inc., Diagnostics Inc.D.S.k.

根据产品类型，连续血糖监测设备（CGMD）市场可分为感测器、发射器和接收器。 2024年，感测器部分占据了最大的市场份额。

依应用领域划分，市场可分为第1型糖尿病和第2型糖尿病。 2024年，第2型糖尿病领域占据了连续血糖监测设备（CGMD）市场最大的份额。

依检测部位划分，市场可分为指尖检测和其他部位检测。 2024年，指尖检测在连续血糖监测设备（CGMD）市场中占据最大份额。指尖血糖检测，也称为自我血糖监测（SMBG），长期以来一直是糖尿病管理的基础。它透过刺穿手指并将一滴血滴到血糖仪上，直接读取毛细血管血液样本。儘管连续血糖监测仪（CGM）因其连续且注重趋势的资料而日益占据主导地位，但指尖采血对于校准（在某些CGM中）以及在血糖快速变化或怀疑测量错误时进行确认仍然至关重要。

准确性仍然是自我血糖监测 (SMBG) 的优势之一。现代指尖血糖仪的平均绝对相对差异 (MARD) 通常较低，一般在 5-6% 范围内，而 Dexcom G7 和 FreeStyle Libre 3 等顶级动态血糖监测仪 (CGM) 的 MARD 则在 8-9% 左右。这种准确性优势在需要精确血糖读数的情况下尤其重要，例如确认低血糖或校准 CGM。延迟时间和组织液与毛细血管液的差异仍然是关键差异。 CGM 测量的是组织液葡萄糖，其读数通常比血糖滞后​​约 5-15 分钟。而指尖血糖检测可以立即提供真实的毛细血管葡萄糖水平，因此在血糖快速变化或设备警报与症状不符时，指尖血糖检测尤为重要。

就最终用户而言，持续血糖监测设备（CGMD）市场可细分为医院和诊所，以及自我或居家照护。到2024年，自我或居家照护细分市场占据了持续血糖监测设备（CGMD）市场的最大份额。

在连续血糖监测设备 (CGMD) 市场中营运的公司采用多种有机和无机成长策略。有机成长策略主要包括产品发布和产品批准。无机成长策略则包括收购、合作和伙伴关係。这些成长策略使市场参与者能够拓展业务、增强地域覆盖范围，并促进整体市场成长。此外，收购和伙伴关係还有助于巩固客户基础并扩展产品组合。以下列举了部分主要连续血糖监测设备 (CGMD) 市场参与者的重要发展动态。

2025年7月，雅培公司两款新型非处方（OTC）连续血糖监测系统Lingo和Libre Rio获得美国食品药物管理局（FDA）批准。这两款产品均基于FreeStyle Libre技术，将血糖监测的应用范围从传统的糖尿病管理扩展到一般健康和保健领域。这是物联网医疗设备消费化过程中的重要一步。

2025年7月，德康医疗（Dexcom, Inc.）宣布，其为Stelo（美国首款获得FDA批准的非处方血糖生物感测器）推出了一项全新的AI驱动的餐食照片记录功能。 Dexcom的智慧餐点记录功能旨在鼓励并帮助使用者更规律地记录膳食。 Stelo和Dexcom G7用户现在可以在应用程式中拍摄食物照片，AI会自动识别食材并产生餐点描述。 Dexcom G7是美国目前唯一支援餐点照片记录功能的处方级连续血糖监测仪。

2025年4月，德康公司宣布，美国食品药物管理局（FDA）已批准其Dexcom G7 15天连续血糖监测系统用于美国18岁以上糖尿病患者。 Dexcom G7 15天连续血糖监测系统整体平均绝对相对偏差（MARD）为8.0%，其性能优于Dexcom CGM，经临床验证可降低糖化血红蛋白（A1C）水平，减少高血糖和低血糖，并增加血糖达标时间。

目录

第一章：引言

第二章：执行概要

  • 分析师市场展望
  • 市场吸引力

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：
  • 假设和局限性

第四章：连续血糖监测设备（CGMD）市场概况

  • 概述
  • PEST分析

第五章：连续血糖监测设备（CGMD）市场－主要市场动态

  • 连续血糖监测设备（CGMD）市场－主要市场动态
  • 市场驱动因素
    • 全球糖尿病盛行率不断上升
    • CGM设备技术的快速发展
    • 与传统血糖监测相比的优势
  • 市场限制
    • 高昂的成本和有限的报销
    • 使用者舒适度和配戴舒适度方面的挑战
  • 市场机会
    • 提高新兴市场和欠发达市场的可近性
  • 未来趋势
    • 与胰岛素输送和人工智慧驱动的决策支援系统集成
  • 驾驶员和安全带的影响：

第六章：连续血糖监测设备（CGMD）市场－全球市场分析

  • 2021-2031年连续血糖监测设备（CGMD）市场收入
  • 连续血糖监测设备（CGMD）市场预测分析

第七章：连续血糖监测设备（CGMD）市场分析－依产品分类

  • 感应器
  • 发射器
  • 接收器

第八章：连续血糖监测设备（CGMD）市场分析－依应用领域划分

  • 1型糖尿病
  • 2型糖尿病

第九章：连续血糖监测设备（CGMD）市场分析－依检测点划分

  • 指尖测试
  • 备选测试地点

第十章：连续血糖监测设备（CGMD）市场分析－依最终使用者划分

  • 医院和诊所
  • 自我照顾或居家护理

第十一章：连续血糖监测设备（CGMD）市场－地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十二章：竞争格局

  • 关键参与者热力图分析
  • 公司定位与集中度

第十三章：全球连续血糖监测设备市场产业概况

  • 概述
  • 产品上市，产品审批
  • 扩张及其他策略发展

第十四章：公司简介

  • Abbott Laboratories
  • Dexcom Inc
  • Ypsomed Holding AG
  • Medtronic Plc
  • F. Hoffmann-La Roche Ltd
  • Senseonics Holdings Inc
  • i-SENS Inc
  • A. Menarini Diagnostics s.r.l
  • Tandem Diabetes Care Inc
  • Medtrum Technologies Inc.

第十五章：附录

Product Code: TIPRE00018031

The continuous glucose monitoring device (CGMD) market is projected to reach US$33.21 billion by 2031 from US$12.71 billion in 2024. The market is estimated to register a CAGR of 14.9% during 2025-2031. Major factors driving the market growth include a rising global prevalence of diabetes, technological advancements in CGM devices, and benefits over conventional glucose monitoring are propelling the adoption of continuous glucose monitoring device (CGMD). Further, integration with insulin delivery and AI-driven decision support will likely boost the market during the forecast period. However, the high cost and limited reimbursement and user comfort and wearability challenges are among the market deterrents.

Continuous glucose monitoring (CGM) devices offer substantial and clinically meaningful advantages over conventional blood glucose monitoring methods, fundamentally transforming diabetes management for millions worldwide. Unlike traditional approaches that rely on periodic finger-prick tests, CGMs provide real-time, continuous measurement of glucose levels via minimally invasive sensors, allowing users and clinicians to assess glucose variability and trends rather than single data points. Recent clinical studies report that CGM use achieves reductions in HbA1c levels ranging from 0.25% to 3.0% and improves "time in range" (the percentage of time glucose remains within target levels) by 15-34%, both of which are associated with lower risk of diabetes complications and improved long-term outcomes.

One of the most impactful developments in CGM technology is its ability to deliver real-time alerts for hypoglycemia and hyperglycemia. These alarms enable immediate intervention, such as prompt carbohydrate consumption or insulin dose adjustment, drastically reducing the frequency and severity of dangerous episodes. Studies show that low-glucose prediction algorithms integrated in newer CGMs can reduce time below range by up to 92% compared to no alerts and 47% compared to standard alerts, significantly improving safety, especially during sleep or for patients at high risk of hypoglycemia. Additionally, nocturnal low-glucose prediction technology has demonstrated a 37% reduction in nightly time spent below the safe glucose threshold, providing substantial protection during vulnerable hours.

CGMs are transformational educational tools, motivating personalized lifestyle change by mapping dietary intake, physical activity, medication response, and stress factors to corresponding glucose fluctuations. This ongoing visual feedback enhances self-management skills and patient engagement, offering insights far superior to conventional education methods that lack immediate and personalized physiological data. Such continuous data streams enable dynamic diabetes management, allowing patients and healthcare providers to make proactive, evidence-based decisions, adjust therapy between clinic visits, and recognize previously unnoticed patterns such as postprandial spikes or nocturnal highs.

CGM also delivers a detailed and comprehensive glucose profile for healthcare providers, including metrics such as time in range, hypoglycemia/hyperglycemia frequency, and glycemic variability. This enables more precise treatment intensification, risk stratification, and preventive strategies to lower hospitalization rates and avoid severe complications. The capability to remotely monitor patient data, enhanced by integrated wireless data transmission and cloud-based storage, streamlines care delivery and boosts adherence. This is particularly beneficial for vulnerable groups, including children, the elderly, pregnant women, and individuals with impaired awareness of hypoglycemia.

CGMs eliminate the practical and psychological burden of frequent finger sticks, a limitation that impaired adherence and quality of life with earlier methods. Children particularly value this "finger-prick-free" approach, and patients undergoing intensive therapy report higher treatment satisfaction and long-term device retention rates despite cost and device complexity challenges.

CGM encompasses dramatic improvements in glycemic control statistics, hypoglycemia prevention, patient empowerment through real-time data, holistic healthcare-team support with actionable metrics, and enhanced overall quality of life. With these clinically validated benefits, international diabetes care standards strongly recommend CGM for type 1 diabetes and expanding indications for type 2 diabetes. This reinforces CGM's role as a cornerstone of modern diabetes care.

The comparative company analysis evaluates and categorizes the continuous glucose monitoring device (CGMD) market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global continuous glucose monitoring device (CGMD) market. The key market players are Abbott Laboratories; Dexcom Inc., Ypsomed Holding AG, Medtronic, F. Hoffmann-La Roche Ltd, Senseonics Holdings Inc, i-SENS Inc., A. Menarini Diagnostics s.r.l, Tandem Diabetes Care, Inc., and Medtrum Technologies Inc.

Based on product, the continuous glucose monitoring device (CGMD) market is segmented into sensors, transmitters, and receivers. The sensors segment held the largest share of the market in 2024.

By application, the market is categorized into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment accounted for the largest continuous glucose monitoring device (CGMD) market share in 2024.

By testing sites, the market is categorized into fingertip testing and alternate site testing. The fingertip testing segment accounted for the largest share of the continuous glucose monitoring device (CGMD) market in 2024. Fingertip blood glucose testing, also known as self-monitoring of blood glucose (SMBG), has long been the foundation of diabetes management. It offers direct capillary blood readings by pricking a finger and applying a drop to a meter. Though CGMs increasingly dominate due to their continuous and trend-focused data, finger sticks remain essential for calibration (in some CGMs) and confirmation during rapid glucose changes or suspected measurement errors.

Accuracy remains one of SMBG's advantages. Modern fingerstick meters typically demonstrate lower Mean Absolute Relative Difference (MARD), often in the 5-6% range, compared to around 8-9% for top-tier CGMs such as the Dexcom G7 and FreeStyle Libre 3. This edge in accuracy is particularly valuable in situations requiring precise glucose readings, such as confirming hypoglycemia or calibrating CGMs. Lag time and interstitial vs. capillary fluid differences remain key distinctions. CGMs measure interstitial fluid glucose, which typically lags behind blood glucose by ~5-15 minutes. Behind actual blood glucose, Fingerstick testing provides immediate access to true capillary glucose levels, making it invaluable when rapid changes occur or device alerts seem inconsistent with symptoms.

Regarding end user, the continuous glucose monitoring device (CGMD) market is segmented into hospitals and clinics, and self or homecare. The self or homecare segment held the largest share of the continuous glucose monitoring device (CGMD) market in 2024.

Companies operating in the continuous glucose monitoring device (CGMD) market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key continuous glucose monitoring device (CGMD) market players are listed below.

In July 2025, Abbott obtained FDA approvals for two new over-the-counter (OTC) continuous glucose monitoring systems, Lingo and Libre Rio. These are based on the FreeStyle Libre technology, expanding access to glucose monitoring beyond traditional diabetes management to general health and wellness. This is a major step in consumerizing IoT medical devices.

In July 2025, DexCom, Inc. announced it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the US. Dexcom's Smart Food Logging feature encourages and enables users to log their meals more consistently. Stelo and Dexcom G7 users can now take a photo of their food in the app, where AI will automatically identify the ingredients and populate the meal description. Dexcom G7 is the US's only prescription continuous glucose monitors to support photo logging.

In April 2025, DexCom, Inc. announced the FDA has cleared the Dexcom G7 15-Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0%,3 Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Continuous Glucose Monitoring Device (CGMD) Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics

  • 5.1 Continuous Glucose Monitoring Device (CGMD) Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Global Prevalence of Diabetes
    • 5.2.2 Growing Technological Advancements in CGM Devices
    • 5.2.3 Benefits Over Conventional Glucose Monitoring
  • 5.3 Market Restraints
    • 5.3.1 High Cost and Limited Reimbursement
    • 5.3.2 User Comfort and Wearability Challenges
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Accessibility in Emerging and Underserved Markets
  • 5.5 Future Trends
    • 5.5.1 Integration with Insulin Delivery and AI-Driven Decision Support
  • 5.6 Impact of Drivers and Restraints:

6. Continuous Glucose Monitoring Device (CGMD) Market - Global Market Analysis

  • 6.1 Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2021-2031
  • 6.2 Continuous Glucose Monitoring Device (CGMD) Market Forecast Analysis

7. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by Product

  • 7.1 Sensors
    • 7.1.1 Overview
    • 7.1.2 Sensors: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Transmitters
    • 7.2.1 Overview
    • 7.2.2 Transmitters: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Receivers
    • 7.3.1 Overview
    • 7.3.2 Receivers: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

8. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by Application

  • 8.1 Type 1 Diabetes
    • 8.1.1 Overview
    • 8.1.2 Type 1 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Type 2 Diabetes
    • 8.2.1 Overview
    • 8.2.2 Type 2 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

9. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by Testing Sites

  • 9.1 Fingertip Testing
    • 9.1.1 Overview
    • 9.1.2 Fingertip Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Alternate Site Testing
    • 9.2.1 Overview
    • 9.2.2 Alternate Site Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

10. Continuous Glucose Monitoring Device (CGMD) Market Analysis - by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Self or Homecare
    • 10.2.1 Overview
    • 10.2.2 Self or Homecare: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)

11. Continuous Glucose Monitoring Device (CGMD) Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.2.2 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.2.3 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.2.3.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.2.4 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.2.4.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.2.5 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.2.5.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.2.6 North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.2.6.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.2.7 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.1 North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.2 United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.2.1 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.2.7.2.2 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.2.7.2.3 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.2.7.2.4 United States: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.2.7.3 Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.3.1 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.2.7.3.2 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.2.7.3.3 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.2.7.3.4 Canada: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.2.7.4 Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.4.1 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.2.7.4.2 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.2.7.4.3 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.2.7.4.4 Mexico: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.3 Europe
    • 11.3.1 Europe Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.3.2 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.3.3 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.3.3.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.3.4 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.3.4.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.3.5 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.3.5.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.3.6 Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.6.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.3.7 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.1 Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.2 Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.2.1 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.2.2 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.2.3 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.2.4 Germany: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.3 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.3.1 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.3.2 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.3.3 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.3.4 United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.4 France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.4.1 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.4.2 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.4.3 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.4.4 France: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.5 Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.5.1 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.5.2 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.5.3 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.5.4 Italy: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.6 Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.6.1 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.6.2 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.6.3 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.6.4 Spain: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.3.7.7 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.7.1 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.3.7.7.2 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.3.7.7.3 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.3.7.7.4 Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.4.2 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.4.3 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.4.3.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.4.4 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.4.4.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.4.5 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.4.5.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.4.6 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.6.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.4.7 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.1 Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.2 China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.2.1 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.2.2 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.2.3 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.2.4 China: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.3 India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.3.1 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.3.2 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.3.3 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.3.4 India: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.4 Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.4.1 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.4.2 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.4.3 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.4.4 Japan: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.5 South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.5.1 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.5.2 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.5.3 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.5.4 South Korea: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.6 Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.6.1 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.6.2 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.6.3 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.6.4 Australia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.4.7.7 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.7.1 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.4.7.7.2 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.4.7.7.3 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.4.7.7.4 Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.5.2 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.5.3 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.5.3.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.5.4 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.5.4.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.5.5 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.5.5.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.5.6 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.6.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.5.7 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.1 Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.2 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.2.1 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.2.2 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.2.3 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.2.4 Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.7.3 South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.3.1 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.3.2 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.3.3 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.3.4 South Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.7.4 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.4.1 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.4.2 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.4.3 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.4.4 United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.5.7.5 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.5.1 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.5.7.5.2 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.5.7.5.3 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.5.7.5.4 Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
  • 11.6 South and Central America
    • 11.6.1 South and Central America Continuous Glucose Monitoring Device (CGMD) Market Overview
    • 11.6.2 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
    • 11.6.3 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
      • 11.6.3.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Product
    • 11.6.4 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
      • 11.6.4.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Application
    • 11.6.5 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
      • 11.6.5.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Testing Sites
    • 11.6.6 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.6.6.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by End User
    • 11.6.7 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.1 South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.2 Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.2.1 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.6.7.2.2 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.6.7.2.3 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.6.7.2.4 Brazil: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.6.7.3 Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.3.1 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.6.7.3.2 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.6.7.3.3 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.6.7.3.4 Argentina: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User
      • 11.6.7.4 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.4.1 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product
        • 11.6.7.4.2 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application
        • 11.6.7.4.3 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites
        • 11.6.7.4.4 Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning & Concentration

13. Global Continuous Glucose Monitoring Device Market Industry Landscape

  • 13.1 Overview
  • 13.2 Product Launch, Product Approvals
  • 13.3 Expansions And Other Strategic Developments

14. Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Dexcom Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Ypsomed Holding AG
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Medtronic Plc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 F. Hoffmann-La Roche Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Senseonics Holdings Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 i-SENS Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 A. Menarini Diagnostics s.r.l
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Tandem Diabetes Care Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Medtrum Technologies Inc.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 List of Abbreviations

List Of Tables

  • Table 1. Continuous Glucose Monitoring Device (CGMD) Market Segmentation
  • Table 2. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 5. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 6. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 9. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 10. Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 11. Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 12. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 13. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 14. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 15. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 16. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 17. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 18. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 19. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 20. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 21. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 22. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 23. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 24. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 25. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 26. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 27. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 28. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 29. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 30. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 31. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 32. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 33. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 34. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 35. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 36. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 37. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 38. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 39. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 40. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 41. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 42. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 43. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 44. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 45. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 46. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 47. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 48. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 49. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 50. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 51. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 52. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 53. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 54. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 55. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 56. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 57. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 58. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 59. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 61. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 62. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 63. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 64. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 65. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 66. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 67. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 68. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 69. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 70. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 73. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 74. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 77. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 78. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 81. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 82. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 83. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 84. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 85. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 86. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 87. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 88. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 89. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 90. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 91. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 92. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 93. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 94. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 95. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 96. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 97. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 98. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 99. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 100. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 101. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 102. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 105. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 106. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 107. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 108. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 109. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 110. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 113. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 114. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 115. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 116. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 117. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 118. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 119. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 120. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 121. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 122. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 123. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 124. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 125. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 126. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 127. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 128. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 129. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 130. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 131. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 132. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 133. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 134. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 135. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 136. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 137. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 138. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 139. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 140. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 141. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 142. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 143. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 144. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 145. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 146. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 147. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 148. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 149. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 150. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 151. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 152. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 153. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 154. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 155. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 156. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 157. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 158. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 159. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 160. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 161. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 162. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 163. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 164. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 165. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 166. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 167. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 168. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 169. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 170. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 171. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 172. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 173. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 174. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 175. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 176. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 177. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 178. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 179. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 180. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 181. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 182. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 183. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 184. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 185. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 186. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 187. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 188. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 189. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 190. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 191. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 192. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 193. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 194. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 195. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 196. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 197. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 198. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 199. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 200. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 201. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 202. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 203. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 204. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 205. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 206. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 207. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 208. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 209. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 210. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 211. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 212. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 213. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 214. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 215. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 216. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 217. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 218. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 219. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 220. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 221. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 222. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 223. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 224. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 225. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 226. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 227. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 228. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 229. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 230. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Product
  • Table 231. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product
  • Table 232. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 233. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 234. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by Testing Sites
  • Table 235. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Testing Sites
  • Table 236. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 237. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 238. Heat Map Analysis by Key Players
  • Table 239. List of Abbreviations

List Of Figures

  • Figure 1. Continuous Glucose Monitoring Device (CGMD) Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Continuous Glucose Monitoring Device (CGMD) Market Revenue (US$ Million), 2021-2031
  • Figure 5. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Product (2024 and 2031)
  • Figure 6. Sensors: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Transmitters: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Receivers: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Application (2024 and 2031)
  • Figure 10. Type 1 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Type 2 Diabetes: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by Testing Sites (2024 and 2031)
  • Figure 13. Fingertip Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Alternate Site Testing: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Continuous Glucose Monitoring Device (CGMD) Market Share (%) - by End User (2024 and 2031)
  • Figure 16. Hospitals and Clinics: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Self or Homecare: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Continuous Glucose Monitoring Device (CGMD) Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 19. North America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 20. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 21. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 22. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 23. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 24. North America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 25. United States: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Canada: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Mexico: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 29. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 30. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 31. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 32. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 33. Europe: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 34. Germany: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. United Kingdom: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. France: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Italy: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. Spain: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. Rest of Europe: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 41. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 42. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 43. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 44. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 45. Asia Pacific: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 46. China: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. India: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Japan: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. South Korea: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. Australia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 51. Rest of APAC: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 52. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 53. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 54. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 55. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 56. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 57. Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 58. Saudi Arabia: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 59. South Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 60. United Arab Emirates: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 61. Rest of Middle East and Africa: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 63. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Product (2024 and 2031)
  • Figure 64. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Application (2024 and 2031)
  • Figure 65. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Testing Sites (2024 and 2031)
  • Figure 66. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by End User (2024 and 2031)
  • Figure 67. South and Central America: Continuous Glucose Monitoring Device (CGMD) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 68. Brazil: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 69. Argentina: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 70. Rest of South and Central America: Continuous Glucose Monitoring Device (CGMD) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 71. Company Positioning & Concentration